Trial · NCT00430781
Participant flow33
How many started, completed or left each group, period by period.
1 to 20 of 33
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Interim Analysis; 11 February 2008 | STARTED | Combination Therapy: Lapatinib 1500 mg and Pazopanib 800 mg | 59 | |
| Interim Analysis; 11 February 2008 | STARTED | Lapatinib Monotherapy | 58 | |
| Interim Analysis; 11 February 2008 | STARTED | Pazopanib Monotherapy | 60 | |
| Interim Analysis; 11 February 2008 | Ongoing | Combination Therapy: Lapatinib 1500 mg and Pazopanib 800 mg | 23 | |
| Interim Analysis; 11 February 2008 | Ongoing | Lapatinib Monotherapy | 20 | |
| Interim Analysis; 11 February 2008 | Ongoing | Pazopanib Monotherapy | 25 | |
| Interim Analysis; 11 February 2008 | COMPLETED | Combination Therapy: Lapatinib 1500 mg and Pazopanib 800 mg | 0 | |
| Interim Analysis; 11 February 2008 | COMPLETED | Lapatinib Monotherapy | 0 | |
| Interim Analysis; 11 February 2008 | COMPLETED | Pazopanib Monotherapy | 0 | |
| Interim Analysis; 11 February 2008 | NOT COMPLETED | Combination Therapy: Lapatinib 1500 mg and Pazopanib 800 mg | 59 | |
| Interim Analysis; 11 February 2008 | NOT COMPLETED | Lapatinib Monotherapy | 58 | |
| Interim Analysis; 11 February 2008 | NOT COMPLETED | Pazopanib Monotherapy | 60 | |
| Final Analysis; 31 July 2008 | STARTED | Combination Therapy: Lapatinib 1500 mg and Pazopanib 800 mg | 0 | |
| Final Analysis; 31 July 2008 | STARTED | Lapatinib Monotherapy | 78 | |
| Final Analysis; 31 July 2008 | STARTED | Pazopanib Monotherapy | 74 | |
| Final Analysis; 31 July 2008 | Ongoing | Combination Therapy: Lapatinib 1500 mg and Pazopanib 800 mg | 0 | |
| Final Analysis; 31 July 2008 | Ongoing | Lapatinib Monotherapy | 29 | |
| Final Analysis; 31 July 2008 | Ongoing | Pazopanib Monotherapy | 32 | |
| Final Analysis; 31 July 2008 | COMPLETED | Combination Therapy: Lapatinib 1500 mg and Pazopanib 800 mg | 0 | |
| Final Analysis; 31 July 2008 | COMPLETED | Lapatinib Monotherapy | 39 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00430781/flow